Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) EBT Margin: 2020-2024

Historic EBT Margin for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to 16.44%.

  • Oncology Institute's EBT Margin rose 40400.0% to 12.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 14.4%, marking a year-over-year increase of 42100.0%. This contributed to the annual value of 16.44% for FY2024, which is 91900.0% up from last year.
  • Per Oncology Institute's latest filing, its EBT Margin stood at 16.44% for FY2024, which was up 91900.0% from 25.63% recorded in FY2023.
  • In the past 5 years, Oncology Institute's EBT Margin ranged from a high of 0.04% in FY2022 and a low of 25.63% during FY2023
  • In the last 5 years, Oncology Institute's EBT Margin had a median value of 7.9% in 2020 and averaged 11.14%.
  • As far as peak fluctuations go, Oncology Institute's EBT Margin crashed by -255900bps in 2023, and later soared by 91900bps in 2024.
  • Oncology Institute's EBT Margin (Annual) stood at 7.9% in 2020, then grew by 28bps to 5.71% in 2021, then skyrocketed by 99bps to 0.04% in 2022, then crashed by -71013bps to 25.63% in 2023, then soared by 36bps to 16.44% in 2024.
  • Its EBT Margin was 16.44% in FY2024, compared to 25.63% in FY2023 and 0.04% in FY2022.